S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NMC HealthHempstractNavidea BiopharmaceuticalsImmunodiagnostic Systems Holdings PLC (IDH.L)Virios Therapeutics
SymbolOTCMKTS:NMHLYOTCMKTS:HPSTNYSEAMERICAN:NAVBLON:IDHNASDAQ:VIRI
Price Information
Current Price$0.52$0.49$2.38GBX 215$6.19
52 Week RangeN/AN/ABuyN/AN/A
MarketRank™
Overall Score0.50.01.70.51.3
Analysis Score0.00.03.50.00.0
Community Score2.40.02.61.75.0
Dividend Score0.00.00.00.80.0
Ownership Score0.00.01.70.01.7
Earnings & Valuation Score0.00.00.60.00.0
Analyst Ratings
Consensus RecommendationN/AN/ABuyN/AN/A
Consensus Price TargetN/AN/A$7.50N/AN/A
% Upside from Price TargetN/AN/A215.13% upsideN/AN/A
Trade Information
Market Cap$108.27 million$49.30 million$66.60 million£61.89 million$48.48 million
Beta1.16-7.811.94N/AN/A
Average Volume588,296273,587431,8003,451301,992
Sales & Book Value
Annual Revenue$2.06 billionN/A$660,000.00£34.25 millionN/A
Price / Sales0.05N/A100.921.81N/A
CashflowN/AN/AN/AGBX 90.30 per shareN/A
Price / CashN/AN/AN/A2.38N/A
Book ValueN/AN/A($0.05) per shareGBX 187.60 per shareN/A
Price / BookN/A-47.600.01N/A
Profitability
Net IncomeN/AN/A$-10,950,000.00N/AN/A
EPSN/AN/A($0.76)GBX 1.30N/A
Trailing P/E Ratio0.000.00N/A165.380.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-1,310.93%N/AN/A
Return on Equity (ROE)N/AN/A-372.59%N/AN/A
Return on Assets (ROA)N/AN/A-196.42%N/AN/A
Dividend
Annual PayoutN/AN/AN/AGBX 0.02N/A
Dividend YieldN/AN/AN/A0.01%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A1.46%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A6.84%N/A
Current RatioN/AN/A1.19%5.40%N/A
Quick RatioN/AN/A1.19%3.87%N/A
Ownership Information
Institutional Ownership PercentageN/AN/A6.02%N/AN/A
Insider Ownership PercentageN/A28.10%0.49%N/AN/A
Miscellaneous
Employees17,7482132764
Shares Outstanding208.70 million99.69 million27.99 million28.78 million7.83 million
Next Earnings DateN/AN/A3/10/2021 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.